| Mallampati Score for Prediction and Prognosis of Postoperative Mortality and Morbidity and Safety Profiles of Patients Undergoing Laparoscopic Cholecystectomy in Qassim Region (NCT06005701) | Qassim University | 2022-01-01 |
| Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis (NCT04604652) | HighTide Biopharma Pty Ltd | 2021-05-27 |
| Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy (NCT04309773) | Assistance Publique - Hôpitaux de Paris | 2021-04-06 |
| Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus (NCT04510090) | Escient Pharmaceuticals, Inc | 2020-09-07 |
| Linerixibat Long-term Safety, and Tolerability Study (NCT04167358) | GlaxoSmithKline | 2020-07-14 |
| Pharmacokinetics (PKs) and Metabolism of Radiolabelled Linerixibat (NCT03992014) | GlaxoSmithKline | 2019-07-08 |
| Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease (NCT05582447) | Children's Hospital Medical Center, Cincinnati | 2018-04-17 |
| Paternally Inherited Phenotypes in Cholestasis (NCT03337074) | Guy's and St Thomas' NHS Foundation Trust | 2017-02-08 |
| Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis (NCT02966834) | GlaxoSmithKline | 2017-01-11 |
| FGF19 in Obstructive Cholestasis: "Unveil the Signal" (NCT05718349) | Nicole Hildebrand | 2017-01-01 |
| Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome (NCT02936596) | Xiaoli Fan | 2016-12-01 |
| FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) (NCT02922751) | Arbor Research Collaborative for Health | 2016-11-16 |
| Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers (NCT02801981) | GlaxoSmithKline | 2016-06-01 |
| Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants (NCT02420496) | The University of Texas Health Science Center at San Antonio | 2016-06-01 |
| Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD (NCT02357576) | University of Michigan | 2016-05-21 |
| Compassionate Use of Omegaven in Children (NCT02370251) | University of Oklahoma | 2015-06-01 |
| Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia (NCT02267707) | Celgene | 2015-05-27 |
| Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral Nutrition (NCT02663453) | Thammasat University | 2013-12-01 |
| Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis (NCT01998620) | Zhejiang Hisun Pharmaceutical Co. Ltd. | 2013-11-01 |
| Omegaven® as Parenteral Nutrition (NCT02334293) | Carle Foundation Hospital | 2013-10-01 |
| Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT (NCT01879735) | University of Aarhus | 2013-06-01 |
| Preventing Cholestasis Using SMOFLipid® (NCT01585935) | Medical University of Vienna | 2012-06-01 |
| Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones (NCT01683240) | Universitätsklinikum Hamburg-Eppendorf | 2011-02-01 |
| Minimization of IntraLipid Versus Omegaven (NCT01247012) | Children's & Women's Health Centre of British Columbia | 2010-12-01 |
| Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders (NCT01373918) | University of California, Los Angeles | 2010-12-01 |
| Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children (NCT01194063) | Kapiolani Medical Center For Women & Children | 2010-10-20 |
| Retrospective Review of CT and MR in Pediatric Patients With Cholestasis (NCT01252043) | National Taiwan University Hospital | 2010-10-01 |
| Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis (NCT01173159) | Children's Hospital Medical Center, Cincinnati | 2010-07-01 |
| Inter-regional Cohort of Neonatal and Infant Cholestasis in the Greater Southwest Region (NCT02767648) | University Hospital, Toulouse | 2010-05-01 |
| Cholestasis in Extreme Low Birth Weight Infants (ELBW) (NCT01164878) | Medical University of Vienna | 2010-01-01 |
| A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease (NCT00969332) | University of California, Los Angeles | 2009-08-01 |
| Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis (NCT00826020) | University of Nebraska | 2009-05-01 |
| Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease (NCT01739517) | Amarnath, Rathna, M.D. | 2009-03-01 |
| Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants (NCT01062815) | University of Miami | 2009-02-01 |
| Compassionate Use of Omegaven IV Fat Emulsion (NCT00816348) | Cindy Haller | 2008-12-01 |
| Ursodiol for Treating Parenteral Nutrition Associated Cholestasis in Neonates (NCT00846963) | Ibrahim Mohamed | 2008-10-01 |
| Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants (NCT00738101) | Baylor College of Medicine | 2008-09-01 |
| A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP) (NCT00685386) | University of North Carolina, Chapel Hill | 2008-06-01 |
| Cholestasis Prevention: Efficacy of IV Fish Oil (NCT00512629) | Boston Children's Hospital | 2007-07-01 |
| Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children (NCT00392730) | Vanderbilt University | 2006-08-01 |
| Brain Manganese Deposition in High Risk Neonates (NCT00392977) | Vanderbilt University | 2006-08-01 |
| A Trial of Taurine Supplementation in Parenteral Nutrition 1 (NCT00135044) | London North West Healthcare NHS Trust | 2005-06-01 |
| Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation (NCT01073202) | Shanghai Jiao Tong University School of Medicine | 2005-05-01 |
| Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation (NCT00080236) | Conatus Pharmaceuticals Inc. | 2003-11-01 |
| Gabapentin to Treat Itch in Patients With Liver Disease (NCT00058890) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-11-01 |
| Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease (NCT00007033) | National Center for Research Resources (NCRR) | 2000-10-01 |
| Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants (NCT00004410) | Children's Hospital Medical Center, Cincinnati | 1998-06-01 |
| Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis (NCT00004414) | University of Michigan | 1997-09-01 |
| Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease (NCT00004315) | National Center for Research Resources (NCRR) | 1995-11-01 |
| Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid (NCT00007020) | Mirum Pharmaceuticals, Inc. | 1992-01-01 |
| Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease (NCT03072667) | Catherine Cibulskis, MD | |
| Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease (NCT01297933) | Children's Hospital of Philadelphia | |
| Compassionate Use of Omegaven IV Fat Emulsion (NCT02477345) | Northwell Health | |
| Compassionate Use of Omegaven (NCT02778698) | Geisinger Clinic | |
| Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis (NCT02148146) | University of California, San Diego | |
| SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury (NCT02412566) | Baylor College of Medicine | |